USD 29.1 billion
Hospital-Acquired Infections Market Size, Share, Growth Analysis, By Type(Equipment (Sterilization Equipment, Disinfection Equipment), Consumables (Disinfectants, Sterilization Consumables), By Treatment(Antibacterial, Antiviral, Antifungal, Others), By Infection Type(Bloodstream Infections, Ventilator-Associated Pneumonia (VAP), Urinary Tract Infection, Surgical-Site Infection), By End User(Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35I2254 |
Region:
Global |
Published Date: July, 2036
Pages:
242
|Tables:
124
|Figures:
76
Hospital-Acquired Infections Market Insights
Global Hospital-Acquired Infections Market size was valued at USD 30.43 billion in 2022 and is poised to grow from USD30.89 billion in 2023 to USD 34.79 billion by 2031, growing at a CAGR of 1.5% in the forecast period (2024-2031).
Infections are mostly caused by microorganisms including viruses, bacteria, and fungus, as well as parasites. Infections can range from stomach and intestinal infections to lung and respiratory infections, eye and ear infections, hospital-acquired infections, skin infections, and sexually transmitted infections. Cross-infection from the surface and skin of the patient, equipment, and healthcare staff can result in hospital-acquired infections. Sterilization, cleaning and disinfection goods, protective barriers, and endoscope reprocessing items are among the several products and services available to control hospital-acquired infections.
Some of the primary drivers of this market are increased awareness of Hospital Acquired Infections (HAIs), the need to reduce cross infections, the incidence of infectious diseases in healthcare facilities, and supportive government measures to encourage infection control techniques. The implementation of infection prevention guidelines and policies at the hospital, regional, and national levels, as well as the increasing acceptance of monitoring technologies, are fueling growth.
US Hospital-Acquired Infections Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Equipment
Fastest Growth
Equipment
Growth Rate
1.5% CAGR
Global Hospital-Acquired Infections Market, 2021-2028 ($ Bn)
Country Share for North America Region- 2021 (%)
To get more reports on the above market click here to Buy The Report
Hospital-Acquired Infections Market Segmental Analysis
Global Hospital-Acquired Infections Market is segmented by Type, Treatment, Infection Type, End User, and region. Based on Type, the market can be segmented into Equipment (Sterilization Equipment, Disinfection Equipment), Consumables (Disinfectants, Sterilization Consumables, Others), Services. Based on Treatment, the market can be segmented into Antibacterial, Antiviral, Antifungal, Others. Based on Infection Type, the market can be segmented into Bloodstream Infections, Ventilator-Associated Pneumonia (VAP), Urinary Tract Infection, Surgical-Site Infection, Gastrointestinal Infections, Others. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Hospital-Acquired Infections Market Analysis by type
In 2021, Consumables segment dominated the market, accounting for 47.0% of total sales and is anticipated to maintain its dominance throughout the forecast period. This is due to the growing use of consumables in hospitals and ambulatory centers, as well as increased R&D spending by market participants. The COVID-19 pandemic was a significant factor to the consumables segment's dominance. Steris, for example, acquired Emergency Use Authorization (EUA) from the US FDA in April 2020 for respirator decontamination. This enabled the firm to provide a temporary solution for decontaminating compatible N95 or N95-equivalent respirators utilizing STERIS V-PRO Low Temperature Sterilization Systems.
Furthermore, the services segment is expected to have the highest CAGR of 5.2% over the forecast period. These include, among other things, disinfection-as-a-service, the design and execution of infection control strategies, and compliance software. The demand is likely to rise in the next years as a result of increased knowledge and favorable policies supported by government officials.
Global Hospital-Acquired Infections Market By Type, 2021 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Hospital-Acquired Infections Market Regional Insights
North America dominated the market in 2021, accounting for more than 34.0% of total sales. The substantial share can be due to the presence of key players, activities implemented by them in the public and commercial sectors, and increased awareness of HAIs in this region. For example, in December 2020, Ecolab, headquartered in the United States, acquired vanBaerle Hygiene AG in Switzerland. This expanded Ecolab's product line and service capabilities to include a comprehensive spectrum of cleaning, disinfection, and hygiene solutions.
The Asia Pacific market is expected to grow at the fastest rate of 5.7% over the next five years. This is due to an increase in the prevalence of hospital-acquired illnesses and the development of healthcare infrastructure in poor and middle-income countries. The World Health Organization (WHO) reports that the frequency of ICU-acquired infection is two to three times greater in low- and middle-income countries than in high-income nations. Whereas in the United States, device-associated infections are almost 13 times higher. Furthermore, babies in developing nations are more likely than those in high-income countries to suffer healthcare-associated illnesses. According to the WHO, infection rates are 3 to 20 times greater. This is likely to boost market growth, particularly in Latin America, the Middle East, and Africa.
Global Hospital-Acquired Infections Market By Geography, 2021-2028
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Hospital-Acquired Infections Market Dynamics
Hospital-Acquired Infections Market Driver
Rising number of surgical procedures is likely to drive market growth
- The number of surgical procedures performed worldwide has increased significantly throughout the years. Every year, around 235 million major surgical procedures are conducted worldwide, according to the WHO (2019). This is due to the rising frequency of obesity and other lifestyle disorders, an aging population, and an increase in spine injuries and sports-related injuries. As the number of surgical procedures performed grows, so does the demand for various surgical equipment and medical gadgets. Because of the demonstrated benefits of sterilized items and increased awareness about their usefulness in healthcare settings, this is projected to stimulate demand for hospital acquired infection services.
Hospital-Acquired Infections Market Restraint
Concerns regarding the safety of reprocessed instruments is likely to restraint market growth
- Reprocessing reusable medical devices helps healthcare providers save money and reduce waste. Surgical forceps, endoscopes, and stethoscopes are all examples of reusable medical devices. However, there are questions about recycled gadgets' safety and performance. Inadequate instrument cleaning and sterilization can cause the retention of blood, tissue, and other biological waste in reusable devices, increasing the risk of surgical-site infections (SSIs) in patients. The debris may enable microorganisms to survive the subsequent disinfection or sterilization process, potentially leading to HAIs. Inadequate reprocessing can potentially cause tissue irritation from remaining reprocessing materials like chemical disinfectants. These concerns are limiting hospital administrators and clinicians' acceptance of reprocessing.
Request Free Customization of this report to help us to meet your business objectives.
Hospital-Acquired Infections Market Competitive Landscape
The market for hospital acquired infection control is highly competitive. Market participants are launching strategic activities such as customer acquisition, strategic collaborations, distribution network strengthening, and R&D. Key firms are also diversifying their portfolios and investing in new technologies to boost their market share. Steris, for example, expanded its offerings by acquiring Cantel Medical, a significant producer of infection prevention products and services, in June 2021.
Hospital-Acquired Infections Market Top Player’s Company Profiles
- 3M Company
- Abbott Laboratories
- Advanced Sterilization Products Services Inc. (ASP)
- Becton, Dickinson and Company (BD)
- Belimed AG
- BioMérieux SA
- Cantel Medical Corp.
- Getinge Group
- Johnson & Johnson
- Merck & Co., Inc.
- Pfizer Inc.
- Roche Diagnostics Corporation
- Stryker Corporation
- Thermo Fisher Scientific Inc.
- Steris Corporation
- Zimmer Biomet Holdings, Inc.
- Ansell Limited
- Molnlycke Health Care AB
- Cantel Medical Corp.
Hospital-Acquired Infections Market Recent Development
- In September 2021, Sodexo, a global leader in services that improve quality of life, announced that it has expanded its relationship with Ecolab in the United States for the control of hospital-acquired infections through the Protecta Plus program. This program was developed to lower infection risk in hospitals and healthcare facilities by employing Ecolab's Bioquell hydrogen peroxide vapour technology.
- In June 2021, STERIS plc, a global provider of innovative healthcare and life science products and services, announced the completion of its acquisition of Cantel Medical, a global provider of infection control products and services to endoscopy, dental, dialysis, and life sciences customers.
Hospital-Acquired Infections Key Market Trends
- The rise in the prevalence of chronic diseases such as gastroesophageal reflux disease (GERD), IBD, peptic ulcer disease, crohn's disease, diabetes, hypertension, cardiovascular disorders, cancer, and others due to environmental pollution, smoking, unhealthy lifestyles, poor nutrition and diet, and high intake of carcinogenic substances will drive the market for hospital acquired infection control devices. According to the International Diabetes Federation's Diabetes Atlas 10th edition report 2021, 537 million individuals (20-79 years) worldwide are diabetic. This figure is expected to climb to 643 million by 2030 and 783 million by 2045. The increased frequency of chronic disease will increase the number of surgical procedures. As the number of procedures increases, so will the risk of hospital-acquired infections. Infection transmission can be stopped by using adequate sterilization and disinfection procedures. As a result of the increased incidence of chronic illnesses, the rising number of surgical operations may raise the prevalence of hospital acquired infections, thus boosting the demand for hospital acquired infection control products. Thus, the aforementioned aspect is expected to boost the overall market growth of hospital acquired infection control products over the forecast period.
Hospital-Acquired Infections Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our business information services team that collects, collates, co-relates, and analyses the data collected by means of primary exploratory research backed by the robust secondary desk research.
According to our analysis, the presence of numerous microorganisms producing infections in healthcare facility centers, as well as an increase in the prevalence of hospital-acquired illnesses, are expected to drive the worldwide hospital-acquired infections treatment market growth during the forecast period. Along with this rising awareness by many government organizations and key players to educate people about emerging infections acquired during hospital admission, symptoms associated with it, and available treatment options, the hospital-acquired infections treatment market is expected to grow during the forecast period. However, in low-middle income countries, poor healthcare infrastructure and a lack of educational training in infection control are projected to stymie market expansion for hospital-acquired infections therapy during the forecast period.
| Report Metric | Details |
|---|---|
| Market size value in 2019 | USD 29.1 billion |
| Market size value in 2031 | USD 33.77 billion |
| Growth Rate | 1.5% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Hospital-Acquired Infections Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Hospital-Acquired Infections Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Hospital-Acquired Infections Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Hospital-Acquired Infections Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Hospital-Acquired Infections Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Hospital-Acquired Infections Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
